Herpes Zoster (Shingles) and Postherpetic Neuralgia

Sampathkumar, Priya; Drage, Lisa A.; Martin, David P.
March 2009
Mayo Clinic Proceedings;Mar2009, Vol. 84 Issue 3, p274
Academic Journal
Herpes zoster (HZ), commonly called shingles, is a distinctive syndrome caused by reactivation of varicella zoster virus (VZV). This reactivation occurs when immunity to VZV declines because of aging or immunosuppression. Herpes zoster can occur at any age but most commonly affects the elderly population. Postherpetic neuralgia (PHN), defined as pain persisting more than 3 months after the rash has healed, is a debilitating and difficult to manage consequence of HZ. The diagnosis of HZ is usually made clinically on the basis of the characteristic appearance of the rash. Early recognition and treatment can reduce acute symptoms and may also reduce PHN. A live, attenuated vaccine aimed at boosting immunity to VZV and reducing the risk of HZ Is now available and is recommended for adults older than 60 years. The vaccine has been shown to reduce significantly the Incidence of both HZ and PHN. The vaccine is well tolerated, with minor local injection site reactions being the most common adverse event. This review focuses on the clinical manifestations and treatment of HZ and PHN, as well as the appropriate use of the HZ vaccine.


Related Articles

  • Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up. Cunningham; Helgason, Sigurdur; Petursson, Gunnar; Gudmundsson, Sigurdur; Sigurdsson, Johann A // BMJ: British Medical Journal (International Edition);09/30/2000, Vol. 321 Issue 7264, p794 

    Objective: To estimate the frequency, duration, and clinical importance of postherpetic neuralgia after a single episode of herpes zoster.Design: Prospective cohort study with long term follow up.Setting: Primary health care in Iceland.Participants: 421 patients with a single episode of herpes...

  • Herpes Zoster and Postherpetic Neuralgia: Diagnosis and Therapeutic Considerations. Roxas, Mario // Alternative Medicine Review;Jun2006, Vol. 11 Issue 2, p102 

    Herpes zoster (HZ), also known as shingles, is a painful vesicular rash resulting from reactivation of the virus that also causes chickenpox - Varicella zoster virus (VZV). Typically, the rash runs its course in a matter of 4-5 weeks. The pain, however, may persist months, even years, after the...

  • Vaccination Helps Older Adults.  // USA Today Magazine;Dec2008, Vol. 137 Issue 2763, p13 

    The article reports that immunization can prevent or reduce post-therapeutic neuralgia. Immunization can cut the risk for herpes zoster, more commonly known as shingles, according to researchers at the American Pain Society. Potential benefits of immunization for herpes zoster were examined in a...

  • Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands. van Lier, Alies; van Hoek, Albert Jan; Opstelten, Wim; Boot, Hein J.; de Melker, Hester E. // BMC Health Services Research;2010, Vol. 10, p237 

    Background: Herpes zoster (HZ) is a painful disease affecting a considerable part of the elderly. Programmatic HZ vaccination of elderly people may considerably reduce HZ morbidity and its related costs, but the extent of these effects is unknown. In this article, the potential effects and...

  • Improving outcomes in shingles. Lyon, Sue // Practice Nurse;11/10/2006, Vol. 32 Issue 8, p47 

    The article discusses the role of practice nurses in prevention strategies, and particularly in the introduction of a vaccine to protect those at risk from the debilitating pain of shingles. Shingles or herpes zoster is a common disease that can result in severe, long-lasting, debilitating pain....

  • This Experimental Vaccine Reduces The Incidence And Severity Of Shingles.  // RN;Aug2005, Vol. 68 Issue 8, p24 

    Discusses research being done on an experimental vaccine which reduces the incidence and severity of shingles. Reference to a study by M. N. Oxman, M. J. Levin et al, published in the 2005 issue of the "New England Journal of Medicine"; Methodology.

  • Herpes zoster vaccine is safe and effective for older adults.  // BMJ: British Medical Journal (International Edition);9/17/2005, Vol. 331 Issue 7517, preceding p585 

    Reviews a study of the effectiveness of a herpes zoster vaccine for older adults. Question of whether or not a vaccine can prevent herpes zoster and postherpetic neuralgia; Symptoms related to each condition; Review of data related to a study of the vaccine; Results that the herpes zoster...

  • Have You Had Chickenpox? Kosecki, Danielle // Prevention;Jun2008, Vol. 60 Issue 6, p40 

    This article discusses potential health problems that can arise from exposure to varicella zoster, the virus that causes chickenpox. Dragan Djordjevic warns adults that they are at risk for the development of shingles, or possibly a virulent adult chickenpox whose complications include...

  • A Review Of Postherpetic Neuralgia. Flossos, Andrew; Kostakou, Chrysoula // Internet Journal of Pain, Symptom Control & Palliative Care;2006, Vol. 4 Issue 2, p3 

    Postherpetic neuralgia is one of the most feared complications of herpes zoster and one of the most painful conditions seen in pain practice. Both conditions occur much more commonly in elderly patients and immunosuppressed individuals, and stress may be an important instigator of both...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics